← Leaderboards
Brandon Lehrich
University Of Pittsburgh At Pittsburgh
$161,206
Attributed
$161,206
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$161,206 · 1
By mechanism
F30$161,206 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Pat R Levitt$42,762,313
- Reza Zarnegar$10,558,814
- Shivendra Singh$26,555,479
- Youhua Liu$11,880,962
- Bharat Bhushan$1,659,582
Others in their field
Other Rising Stars on “Adaptive Immune Response”
- Angee Greer · Ppd Development Lp$82,531,927
- Anice Lowen · Emory University$10,657,790
- Lisa Wagar · University Of California-Irvine$8,780,203
- Philip Felgner · University Of California-Irvine$8,084,165
- Russell Jones · Van Andel Research Institute$3,253,755
- Baodong Sun · Duke University$3,238,660
Research focus
Adaptive Immune ResponseAnti-Pd1 TherapyAutomobile DrivingAntigen PresentationBay 54-9085Beta CateninBindingBioinformaticsAwardBiomarker DrivenCancer BiologyCancer EtiologyCareerCell ProliferationCellsCell TypeChronic Liver DiseaseClinically RelevantCombinatorialCombined Modality TherapyCtnnb1 GeneDifferential ExpressionDriver MutationEducation
Grant awards (3)
Investigating Immunosuppression in Beta-catenin-mutated Hepatocellular Carcinoma for Improved Precision Medicine Therapeutics$54,538
F30 · FY2025 · CA · contact PI
Investigating Immunosuppression in Beta-catenin-mutated Hepatocellular Carcinoma for Improved Precision Medicine Therapeutics$53,974
F30 · FY2024 · CA · contact PI
Investigating Immunosuppression in Beta-catenin-mutated Hepatocellular Carcinoma for Improved Precision Medicine Therapeutics$52,694
F30 · FY2023 · CA · contact PI